Lv5
1330 积分 2020-08-12 加入
Concomitant or sequential lower intensity triplet therapy in AML
5天前
已关闭
How I treat acute lymphoblastic leukemia in the era of immunotherapy while revisiting the myth of second remission
1个月前
已完结
Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress
1个月前
已完结
Acute lymphocytic leukaemia
1个月前
已完结
Early Driver, Late Bystander: Stage-Specific Roles of DNMT3A R882 Mutations Unveiled in Human AML
1个月前
已完结
Overcoming Menin inhibitor resistance in AML cells with combinations including BET proteins and dual BRG1/BRM inhibitor
1个月前
已关闭
A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT
1个月前
已完结
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents
1个月前
已完结
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations
2个月前
已完结
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
3个月前
已完结
皖公网安备34019202002308
